Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $140.2500 (-0.06%) ($139.8750 - $142.2400) on Tue. Aug. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.38% (three month average) | RSI | 33 | Latest Price | $140.2500(-0.06%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -3.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(34%) DIA(27%) SPLV(26%) VYM(24%) XLP(24%) | Factors Impacting ABBV price | ABBV will decline at least -0.69% in a week (0% probabilities). VIXM(-17%) UUP(-14%) TBT(-3%) UNG(-1%) VXX(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.69% (StdDev 1.38%) | Hourly BBV | 0.8 () | Intraday Trend | -0.3% | | | |
|
1 - 5 Day Possible Target | $135.21(-3.59%) | Resistance Level | $145.94 | 5 Day Moving Average | $139.75(0.36%) | 10 Day Moving Average | $142.16(-1.34%) | 20 Day Moving Average | $145.94(-3.9%) | To recent high | -9.8% | To recent low | 1.9% | Market Cap | $247.441b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |